Skip to main content
. 2023 Feb;26(2):248–254. doi: 10.22038/IJBMS.2022.67445.14780

Table 1.

Tumor weight and tumor inhibition rates of each group of the patient-derived xenograft (PDX) mice

Group Tumor volume
(cm3)
Tumor weight
(g)
Volume inhibition rate
(%)
Tumor weight inhibition rate
(%)
Model 1.76±0.23 2.73±0.49
Capecitabine 200 mg/kg 1.01±0.49* 1.76±0.78 42.61 35.53
Capecitabine 300 mg/kg 0.57±0.33* 0.88±0.43* 67.61 67.77
Capecitabine 400 mg/kg 0.40±0.38* 0.68±0.72* 77.27 75.09

Note: * indicates a significant difference compared with the model group, P<0.05